Stale terms, scheduled reset: the existing book is priced for a world that has moved on
The model's full reasoning — Q2 2018 call → NOWe need answer YES/NO based on transcript. Need determine if management describes meaningful portion existing business carried at prices below current market and coming up for repricing/reset on schedule, improving without new customers. Transcript topics: Calcimimetics transition from Part D to Part B, pharmacy to clinics. This is about existing business? They are moving from one reimbursement to another. Is that repricing? They mention "Calcimimetics; they continue to evolve. As you remember, we're moving from Part D in David to Part B in Barry. Pharmacy to the clinics. We believe that we're probably two quarters in to two to four quarter process in order to get this sorted out with great clarity in detail." This is about existing patients? It's a medical decision, titration. It affects revenue/cost per treatment. But is it "prices, rates, or terms set in the past below current market"? Not exactly. It's a shift in reimbursement channel, not necessarily market repricing. Also they guide net effect $1 loss for year. So not improvement. Other topics: ESRD PPS draft rule 2019 proposed increase 1.7%. That's future rate change, not existing book reset? It's government rate for dialysis. But management doesn't describe as existing business at below market and resetting. They just note proposal. Sound divestiture, Care Coordination margins, etc. Question asks: Does management describe that a meaningful portion existing business is still carried at prices/rates/terms set in past that are now clearly below current market conditions AND that this existing business is coming up for repricing/renewal/reset on schedule management can already see, so economics improve as older terms roll off without needing new customers? Look for any mention of "legacy pricing", "contracts renewing", "hedges rolling off", "rate increases", "escalators". None. The only possible is Calcimimetics transition from Part D to Part B. But that's not "below current market" - it's a change in reimbursement mechanism, and they expect net loss. Also they say "we're probably two quarters in to two to four quarter process" - but not about repricing to higher market. It's about sorting out. Also "ESRD PPS draft rule for 2019 came out with proposed increase of 1.7%" - that's future government payment increase, not existing book reset.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| SNV | Synovus Financial Corp. | Q1 2024 | 2024-04-18 | B |
| FISI | Financial Institutions, Inc. | Q4 2023 | 2024-01-26 | B |
| UMBF | UMB Financial Corporation | Q3 2022 | 2022-10-26 | C+ |
| CRK | Comstock Resources, Inc. | Q2 2022 | 2022-08-02 | B+ |
| ADSK | Autodesk, Inc. | Q3 2019 | 2018-11-20 | A |
| T | AT&T Inc. | Q3 2018 | 2018-10-24 | C+ |
| DBX | Dropbox, Inc. | Q2 2018 | 2018-08-09 | B |
| ESS | Essex Property Trust, Inc. | Q2 2018 | 2018-08-03 | B+ |
| PTC | PTC Inc. | Q3 2017 | 2017-07-19 | C+ |
| BDN | Brandywine Realty Trust | Q1 2017 | 2017-04-21 | C+ |
FISI · Q4 2023 → YESThe question is about whether management describes a meaningful portion of the existing business being carried at below-current-market terms, and that it's coming up for repricing on a visible schedul...YES The transcript shows management describing exactly this situation for the company's existing loan and securities portfolios (yields rolling off) and for a meaningful portion of its deposit book (the money-market campaign with 12-month guarantees that reset in July 2024). Jack Plants explicitly ties the expected margin expansion to these scheduled repric ings and redeployments of existing cash flows, stating that the improvement is already embedded in the company's current commitments and does not require new customers or demand. This matches the criteria for a "meaningful portion" of the existing business coming up for repricing on a visible schedule. The answer is therefore YES.
PTC · Q3 2017 → YESThe question is about whether management describes a meaningful portion of the existing business being carried at below-current-market prices/terms that are coming up for repricing on a visible schedu...YES Management describes a meaningful portion of the existing business (large enterprise customers on volume purchase agreements / perpetual licenses with discounted maintenance) being carried at below-current off-the-shelf rates. These older terms are expiring on a visible schedule (many in Q4 2017), creating a compelling event where customers must either convert 50%+ ACV uplift to subscription or renew maintenance at 25% higher rates. This repricing is already embedded in the existing book and will improve economics without new customers or demand, as confirmed by the large pipeline of such opportunities and the fact that most large deals are already moving to subscription.
UMBF · Q3 2022 → YESThe question is about whether management describes a meaningful portion of the existing business being carried at below-current-market terms that will reprice/reset on a known schedule, improving econ...YES The transcript shows management describing a meaningful portion of the existing loan book carried at past terms that are now below current market levels, with repricing already scheduled: 61% of loans (~$12.1 billion) are variable-rate, 60% repricing in the next quarter and 71% within 12 months, tied to short-end indices. Loan yields rose 74 bp quarter-over-quarter to 4.46% (cycle-to-date beta 37%), and the securities portfolio is rolling off at ~1.83% yield while cash flows fund higher-yielding loans.